Biocon continues to trade higher for yet another session on BSE

05 Dec 2014 Evaluate

Biocon is currently trading at Rs. 471.65, up by 1.25 points or 0.27% from its previous closing of Rs. 470.40 on the BSE.

The scrip opened at Rs. 471.00 and has touched a high and low of Rs. 474.35 and Rs. 470.00 respectively. So far 21109 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 553.70 on 04-Jul-2014 and a 52 week low of Rs. 378.85 on 13-Dec-2013.

Last one week high and low of the scrip stood at Rs. 475.50 and Rs. 453.35 respectively. The current market cap of the company is Rs. 9470.00 crore.

The promoters holding in the company stood at 60.97 % while Institutions and Non-Institutions held 20.00 % and 19.03 % respectively.

Biotechnology firm Biocon and US-based CytoSorbents Corporation have expanded their partnership to develop a therapy intended to treat whole body inflammation caused by various diseases. Biocon will now have the exclusive, region-wide rights to distribute CytoSorb for all critical care applications in the intensive care unit (ICU) as well as cardiac surgery applications for India and select emerging countries. The company will also play a prominent role in the generation of new clinical evidence to support the adoption and usage of CytoSorb. 

Biocon is India’s largest and Asia's leading biotechnology company with a strategic focus on biopharmaceuticals and research services. The company has registered 90.23% rise in its net profit at Rs 181.52 crore for Q2FY15 as compared to Rs 95.42 crore for the same quarter in the previous year.

Biocon Share Price

392.80 4.55 (1.17%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×